Home › Trial NCT00004062
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
- Trial IDNCT00004062
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorLucille P. Markey Cancer Center at University of Kentucky
- Enrollment—
- Start date1999-07
- ConditionsHead and Neck Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.